How do I contact Genentech?
By Daniel Avila
How do I contact Genentech?
Call us at (877) 436-3683 or (877) GENENTECH, Monday-Friday, 6am-5pm PT. Provides free medicine to patients without insurance coverage or who can’t pay for their Genentech medicine.
Is Genentech a member of the Roche Group?
A Member of the Roche Group. Genentech became a member of the Roche Group in March of 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in…
What does Genentech do for a living?
About Us. Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world’s leading biotech companies, with multiple products on the market and a promising development pipeline.
What happened to Genentech in the year 1995?
1995: Roche agrees to extend its option to buy remainder of Genentech for four more years; Genentech board forces CEO G. Kirk Raab to resign after allegations of ethical improprieties arise; Dr. Arthur Levinson is named as successor. 1996: Nutropin AQ, the first liquid HGH and Genentech’s third HGH product, receives FDA approval.
Phone: 1 (877) GENENTECH (436-3683) Hours: Monday – Friday, 6am – 5pm PST. Report an Adverse Event. Report a side effect or harmful experience while taking a Genentech medicine. Phone: (888) 835-2555 Hours: 24 hrs/day, 7 days/week. Mail: Genentech US Drug Safety 1 DNA Way Mailstop 258A South San Francisco, CA 94080. Fax: (650) 225-4630
Where are Roche and Genentech headquarters located?
As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States.
When was Genentech approved by the FDA for cancer treatment?
On November 6, 2017, the FDA approved a Genentech medicine for the treatment of people with a specific type of lung cancer. On June 22, 2017, the FDA approved a Genentech medicine for subcutaneous (under the skin) injection for the treatment of certain blood cancers.
How many gengenentech drugs are in the US?
Genentech, Inc. manufactures, markets and/or distributes more than 41 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
